SHTPY Stock Financial Analysis - SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) (OTCPK) Stock

Overview

SCHOTT Pharma AG & Co. KGaA is a renowned company based in Germany, specializing in the pharmaceutical and healthcare sector. Primarily, the company excels in the development and production of high-quality primary pharmaceutical packaging and drug delivery systems. SCHOTT Pharma is notable for its extensive range of glass and polymer products, offering solutions that significantly contribute to safe and effective medication storage and delivery. Their key projects often focus on innovation in pharmaceutical glass, with advancements such as the SCHOTT TOPPAC® syringe system and specialized glass coatings that enhance the shelf life and stability of medications. These endeavors underscore its commitment to enhancing patient safety and supporting the pharmaceutical industry's complex needs.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is 975.68 MM.
The operating income for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is 198.86 MM.
The net income for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is 146.87 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	975.68	198.86	146.87
2025-03-31	972.80	182.69	147.57
2024-12-31	954.68	180.47	134.17
2024-09-30	957.09	188.84	149.69
2024-06-30	948.56	175.24	150.41
2024-03-31	916.32	171.16	134.63
2023-12-31	905.64	171.11	158.11
2023-09-30	898.60	171.21	151.84
2023-06-30	873.12	164.56	142.73
2022-09-30	821.14	168.01	125.38
2021-09-30	648.67	114.50	100.75
2020-09-30	584.23	90.97	77.48

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30
2025-03-31
2024-12-31	0.89	0.89
2024-09-30	0.99	0.99
2024-06-30	1.00	1.00
2024-03-31	0.89	0.89
2023-12-31	1.05	1.05
2023-09-30	1.01	1.01
2023-06-30	0.95	0.95
2022-09-30	0.83	0.83
2021-09-30	0.67	0.67
2020-09-30	0.51	0.51

Cash Flow: Operations, Investing, Financing

The cash from operating activities for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is 203.56 MM.
The cash from investing activities for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is -152.69 MM.
The cash from financing activities for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is -43.06 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	203.56	-152.69	-43.06
2025-03-31	206.30	-139.02	-58.69
2024-12-31	183.69	-138.28	-47.88
2024-09-30	225.33	-145.93	-78.16
2024-06-30	190.99	-166.51	-21.30
2024-03-31	175.04	-174.93	-0.38
2023-12-31	219.88	-179.76	-45.02
2023-09-30	181.65	-171.41	-11.39
2023-06-30	217.23	-134.55	-85.66
2022-09-30	182.12	-142.13	-42.38
2021-09-30	132.21	-95.89	-27.50
2020-09-30	104.40	-81.22	-14.45

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2022-09-30
2021-09-30
2020-09-30

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2022-09-30
2021-09-30
2020-09-30

Management Effectiveness

The roa for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.11.
The roe for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.19.
The roic for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.13.
The croic for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.01.
The ocroic for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.18.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	0.11	0.19	0.13	0.01	0.18
2025-03-31	0.11	0.19	0.12	-0.00	0.16
2024-12-31	0.12	0.21	0.14	-0.00	0.21
2024-09-30	0.12	0.22	0.14	0.00	0.18
2024-06-30		0.19	0.15	-0.00	0.19
2024-03-31	0.13	0.22	0.17	-0.01	0.24
2023-12-31	0.13	0.21	0.17	-0.00	0.20
2023-09-30			0.17	-0.01	0.26
2023-06-30			0.17	-0.01	0.26
2022-09-30	0.17	0.30	0.14	0.00	0.20
2021-09-30	0.17	0.32	0.19	0.02	0.25
2020-09-30			0.19	0.01	0.26

Gross Margins

The gross margin for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.33.
The net margin for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.15.
The operating margin for SCHOTT Pharma AG & Co. KGaA - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.19.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.33	0.15	0.19
2025-03-31	0.33	0.14	0.19
2024-12-31	0.34	0.16	0.20
2024-09-30	0.34	0.16	0.20
2024-06-30	0.34	0.15	0.18
2024-03-31	0.35	0.17	0.20
2023-12-31	0.35	0.17	0.19
2023-09-30	0.35	0.16	0.20
2023-06-30	0.35	0.16	0.20
2022-09-30	0.36	0.15	0.20
2021-09-30	0.35	0.16	0.18
2020-09-30	0.34	0.13	0.16